The United States Food and Drug Administration (USFDA) has conducted an inspection at the new state-of-the-art multipurpose API manufacturing facility of Solara Active Pharma Sciences at Visakhapatnam (Vizag), Andhra Pradesh. The Agency, with its designated investigator, inspected the facility from January 23, 2023 to January 26, 2023. The inspection established that the site is in an Acceptable State of Compliance with Zero Form 483 inspectional observations from the agency.
Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.
